{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:24:52Z","timestamp":1758709492147},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,9,16]],"date-time":"2004-09-16T00:00:00Z","timestamp":1095292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00262-004-0590-0","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T19:25:28Z","timestamp":1095449128000},"page":"149-156","source":"Crossref","is-referenced-by-count":26,"title":["Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?"],"prefix":"10.1007","volume":"54","author":[{"given":"Zahra","family":"Madjd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindy G.","family":"Durrant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Ronan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil K.","family":"Rushmere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Spendlove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,9,16]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.893","volume":"195","author":"L Bubendorf","year":"2001","unstructured":"Bubendorf L, Nocito A, Moch H, Sauter G (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195:72?79","journal-title":"J Pathol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1073\/pnas.82.3.859","volume":"82","author":"JL Cole","year":"1985","unstructured":"Cole JL, Housley GA Jr, Dykman TR, MacDermott RP, Atkinson JP (1985) Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A 82:859?863","journal-title":"Proc Natl Acad Sci U S A"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4049\/jimmunol.148.3.672","volume":"148","author":"M Deckert","year":"1992","unstructured":"Deckert M, Kubar J, Bernard A (1992) CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J Immunol 148:672?677","journal-title":"J Immunol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/(SICI)1521-4141(199903)29:03<815::AID-IMMU815>3.0.CO;2-8","volume":"29","author":"P Devaux","year":"1999","unstructured":"Devaux P, Christiansen D, Fontaine M, Gerlier D (1999) Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation. Eur J Immunol 29:815?822","journal-title":"Eur J Immunol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.1992.tb01032.x","volume":"20","author":"IO Ellis","year":"1992","unstructured":"Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW (1992) Pathological prognostic factors in breast cancer, II: histological type?relationship with survival in a large study with long-term follow-up. Histopathology 20:479?489","journal-title":"Histopathology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer, I: the value of histological grade in breast cancer?experience from a large study with long-term follow-up. Histopathology 19:403?410","journal-title":"Histopathology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","volume":"22","author":"MH Galea","year":"1992","unstructured":"Galea MH, Blamey RW, Elston CE, Ellis IO (1992) The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 22:207?219","journal-title":"Breast Cancer Res Treat"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.1377404","volume":"256","author":"WC Hahn","year":"1992","unstructured":"Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE (1992) Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science 256:1805?1807","journal-title":"Science"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.184.3.1185","volume":"184","author":"J Hamann","year":"1996","unstructured":"Hamann J, Vogel B, van Schijndel GM, van Lier RA (1996) The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 184:1185?1189","journal-title":"J Exp Med"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1982.62","volume":"45","author":"JL Haybittle","year":"1982","unstructured":"Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K (1982) A prognostic index in primary breast cancer. Br J Cancer 45:361?366","journal-title":"Br J Cancer"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00665772","volume":"32","author":"P Hofman","year":"1994","unstructured":"Hofman P, Hsi BL, Manie S, Fenichel P, Thyss A, Rossi B (1994) High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack? Breast Cancer Res Treat 32:213?219","journal-title":"Breast Cancer Res Treat"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.151.3.1519","volume":"151","author":"A Kojima","year":"1993","unstructured":"Kojima A, Iwata K, Seya T, Matsumoto M, Ariga H, Atkinson JP, Nagasawa S (1993) Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis. J Immunol 151:1519?1527","journal-title":"J Immunol"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844?847","journal-title":"Nat Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.4049\/jimmunol.146.12.4092","volume":"146","author":"PE Korty","year":"1991","unstructured":"Korty PE, Brando C, Shevach EM (1991) CD59 functions as a signal-transducing molecule for human T cell activation. J Immunol 146:4092?4098","journal-title":"J Immunol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1054\/bjoc.2000.1570","volume":"84","author":"L Li","year":"2001","unstructured":"Li L, Spendlove I, Morgan J, Durrant LG (2001) CD55 is over-expressed in the tumour environment. Br J Cancer 84:80?86","journal-title":"Br J Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.iy.09.040191.002243","volume":"9","author":"MK Liszewski","year":"1991","unstructured":"Liszewski MK, Post TW, Atkinson JP (1991) Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 9:431?455","journal-title":"Annu Rev Immunol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0065-2776(08)60868-8","volume":"61","author":"MK Liszewski","year":"1996","unstructured":"Liszewski MK, Farries TC, Lublin DM, Rooney IA, Atkinson JP (1996) Control of the complement system. Adv Immunol 61:201?283","journal-title":"Adv Immunol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/path.1357","volume":"200","author":"Z Madjd","year":"2003","unstructured":"Madjd Z, Pinder SE, Paish C, Ellis IO, Carmichael J, Durrant LG (2003) Loss of CD59 expression in breast tumours correlates with poor survival. J Pathol 200:633?639","journal-title":"J Pathol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1158\/1078-0432.CCR-1073-03","volume":"10","author":"Z Madjd","year":"2004","unstructured":"Madjd Z, Durrant LG, Bradley R, Spendlove I, Ellis IO, Pinder SE (2004) Loss of CD55 is associated with aggressive breast tumors. Clin Cancer Res 10:2797?2803","journal-title":"Clin Cancer Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI114196","volume":"84","author":"T McNearney","year":"1989","unstructured":"McNearney T, Ballard L, Seya T, Atkinson JP (1989) Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest 84:538?545","journal-title":"J Clin Invest"},{"key":"CR21","volume-title":"Complement regulatory proteins","author":"BP Morgan","year":"1999","unstructured":"Morgan BP, Harris CL (1999) Complement regulatory proteins. Academic Press, San Diego"},{"key":"CR22","first-page":"129","volume":"149","author":"GA Niehans","year":"1996","unstructured":"Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP (1996) Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Am J Pathol 149:129?142","journal-title":"Am J Pathol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/0006-291X(89)90852-8","volume":"162","author":"H Okada","year":"1989","unstructured":"Okada H, Nagami Y, Takahashi K, Okada N, Hideshima T, Takizawa H, Kondo J (1989) 20 KDa homologous restriction factor of complement resembles T cell activating protein. Biochem Biophys Res Commun 162:1553?1559","journal-title":"Biochem Biophys Res Commun"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2559.1995.tb00213.x","volume":"27","author":"H Pereira","year":"1995","unstructured":"Pereira H, Pinder SE, Sibbering DM, Galea MH, Elston CW, Blamey RW, Robertson JF, Ellis IO (1995) Pathological prognostic factors in breast cancer, IV: should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27:219?226","journal-title":"Histopathology"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2559.1994.tb01269.x","volume":"24","author":"SE Pinder","year":"1994","unstructured":"Pinder SE, Ellis IO, Galea M, O?Rouke S, Blamey RW, Elston CW (1994) Pathological prognostic factors in breast cancer, III: vascular invasion?relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 24:41?47","journal-title":"Histopathology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1084\/jem.174.1.93","volume":"174","author":"TW Post","year":"1991","unstructured":"Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP (1991) Membrane cofactor protein of the complement system: alternative splicing of serine\/threonine\/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 174:93?102","journal-title":"J Exp Med"},{"key":"CR27","first-page":"155","volume":"70","author":"DF Purcell","year":"1990","unstructured":"Purcell DF, McKenzie IF, Lublin DM, Johnson PM, Atkinson JP, Oglesby TJ, Deacon NJ (1990) The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology 70:155?161","journal-title":"Immunology"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/ijc.11606","volume":"108","author":"NK Rushmere","year":"2004","unstructured":"Rushmere NK, Knowlden JM, Gee JM, Harper ME, Robertson JF, Morgan BP, Nicholson RI (2004) Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer. Int J Cancer 108:930?936","journal-title":"Int J Cancer"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.1830220625","volume":"22","author":"SM Russell","year":"1992","unstructured":"Russell SM, Sparrow RL, McKenzie IF, Purcell DF (1992) Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol 22:1513?1518","journal-title":"Eur J Immunol"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.163.4.837","volume":"163","author":"T Seya","year":"1986","unstructured":"Seya T, Turner JR, Atkinson JP (1986) Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J Exp Med 163:837?855","journal-title":"J Exp Med"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/eji.1830180821","volume":"18","author":"T Seya","year":"1988","unstructured":"Seya T, Ballard LL, Bora NS, Kumar V, Cui W, Atkinson JP (1988) Distribution of membrane cofactor protein of complement on human peripheral blood cells. An altered form is found on granulocytes. Eur J Immunol 18:1289?1294","journal-title":"Eur J Immunol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4049\/jimmunol.145.1.238","volume":"145","author":"T Seya","year":"1990","unstructured":"Seya T, Hara T, Matsumoto M, Akedo H (1990) Quantitative analysis of membrane cofactor protein (MCP) of complement: high expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol 145:238?245","journal-title":"J Immunol"},{"key":"CR33","first-page":"1247","volume":"79","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P (1999) Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest 79:1247?1259","journal-title":"Lab Invest"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.1719635","volume":"254","author":"I Stefanova","year":"1991","unstructured":"Stefanova I, Horejsi V, Ansotegui IJ, Knapp W, Stockinger H (1991) GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 254:1016?1019","journal-title":"Science"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1699-0463.1998.tb00233.x","volume":"106","author":"L Thorsteinsson","year":"1998","unstructured":"Thorsteinsson L, O?Dowd GM, Harrington PM, Johnson PM (1998) The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues. Apmis 106:869?878","journal-title":"Apmis"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.1987.230","volume":"56","author":"JH Todd","year":"1987","unstructured":"Todd JH, Dowle C, Williams MR, Elston CW, Ellis IO, Hinton CP, Blamey RW, Haybittle JL (1987) Confirmation of a prognostic index in primary breast cancer. Br J Cancer 56:489?492","journal-title":"Br J Cancer"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0002-9440(10)63075-1","volume":"159","author":"J Torhorst","year":"2001","unstructured":"Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dieterich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249?2256","journal-title":"Am J Pathol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1021\/bi00199a043","volume":"33","author":"PA Merwe van der","year":"1994","unstructured":"van der Merwe PA, Barclay AN, Mason DW, Davies EA, Morgan BP, Tone M, Krishnam AK, Ianelli C, Davis SJ (1994) Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 33:10149?10160","journal-title":"Biochemistry"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-004-0590-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0590-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T10:00:11Z","timestamp":1682762411000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-004-0590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,16]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1007\/s00262-004-0590-0","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,16]]}}}